This highlights the important role of patient-reported symptoms in identifying important changes in disease activity and severity in SSc.21 Raised inflammatory markers are associated with adverse outcomes in SSc and are considered a marker of early, aggressive disease,22,23 which fits with our observation that raised CRP was associated with increased HAQ-DI scores in incident disease and dcSSc. This evidence concerns the gene CRP and systemic sclerosis.